StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals PSUs — Shares granted in period (M shares) by Year

PSUs — Shares granted in period (M shares) (M)

Vertex Pharmaceuticals PSUs — Shares granted in period (M shares): 0.48M in FY2025, unchanged from a year earlier.

Latest, FY2025
0.48
Period ended Dec 31, 2025
Change on a year earlier
0.0%
0.48 in FY2024
History
9 years
Since FY2017
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Note (Stock-based Compensation — PSU Rollforward).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPSUs — Shares granted in period (M shares) (M)Year on yearSource
FY2025Dec 31, 20250.480.0%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20240.48-17.2%Form 10-K (filed 2025-02-13) ↗
FY2023Dec 31, 20230.58-4.9%Form 10-K (filed 2024-02-15) ↗
FY2022Dec 31, 20220.61-35.8%Form 10-K (filed 2023-02-10) ↗
FY2021Dec 31, 20210.95+72.7%Form 10-K (filed 2022-02-09) ↗
FY2020Dec 31, 20200.55+22.2%Form 10-K (filed 2021-02-11) ↗
FY2019Dec 31, 20190.45-8.2%Form 10-K (filed 2020-02-13) ↗
FY2018Dec 31, 20180.49+25.6%Form 10-K (filed 2019-02-13) ↗
FY2017Dec 31, 20170.39–Form 10-K (filed 2018-02-15) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals PSUs — Shares granted in period (M shares) (M), annual FY2017–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/psu-granted-sh

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.